Boston, MA. Nixon Peabody LLP represented Health Catalyst, Inc. (Health Catalyst, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in its acquisition of next-generation patient engagement platform provider Upfront Healthcare Services, Inc. (Upfront).
Upfront provides a patient activation and engagement platform that analyzes clinical, sociodemographic, and patient-reported data to digitally guide patients to the care they need, helping providers reengage patients, promote appointment attendance, streamline scheduling and referrals, and improve care transitions. Upfront’s automated patient acquisition and retention solutions help strengthen patient loyalty with their healthcare organizations while guiding patients to optimal care.
Health Catalyst funded the transaction with a mix of cash and stock.
“We are thrilled to continue working with Health Catalyst to help the company achieve its growth goals,” said Nixon Peabody Corporate partner Amy O’Keefe, who led the firm’s deal team. “This acquisition supports Health Catalyst and Upfront’s shared mission to create data-informed solutions that ultimately improve patient care and increase engagement with healthcare organizations and providers.”
Read Health Catalyst’s press release here to learn more about the companies.
In addition to O’Keefe, the Nixon Peabody team included partners Gregory O’Shaughnessy, Jeffrey Gilbreth, Thomas McCord, Shahzad Malik, April Schweitzer, Jenny Holmes, Seth Levy, Alexandra López-Casero, Richard Langan, and Rebecca Simone; counsel David Crosby and Jason Kunze; senior attorney Shelagh Michaud; and associates Anthony Bova, Mukta Chilakamarri, Ryan Cosmopulos, Yasmin Hayre, Brian Kenney, Emily Morrison, and Dave Zimmermann.
